199 related articles for article (PubMed ID: 36679972)
21. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
22. COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.
Bradshaw PC; Seeds WA; Miller AC; Mahajan VR; Curtis WM
Oxid Med Cell Longev; 2020; 2020():6401341. PubMed ID: 33014275
[TBL] [Abstract][Full Text] [Related]
23. Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.
Kim BS
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067536
[TBL] [Abstract][Full Text] [Related]
24. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
25. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.
Pasrija R; Naime M
Int Immunopharmacol; 2021 Jan; 90():107225. PubMed ID: 33302033
[TBL] [Abstract][Full Text] [Related]
26. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
[TBL] [Abstract][Full Text] [Related]
27. Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?
Vályi-Nagy I; Uher F; Rákóczi É; Szekanecz Z
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430430
[TBL] [Abstract][Full Text] [Related]
28. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
Conti P; Younes A
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):339-343. PubMed ID: 32253888
[TBL] [Abstract][Full Text] [Related]
29. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
30. Within Host Dynamics of SARS-CoV-2 in Humans: Modeling Immune Responses and Antiviral Treatments.
Ghosh I
SN Comput Sci; 2021; 2(6):482. PubMed ID: 34661166
[TBL] [Abstract][Full Text] [Related]
31. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
[TBL] [Abstract][Full Text] [Related]
32. Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine.
Wang C; Yang S; Duan L; Du X; Tao J; Wang Y; Yang J; Lv Y; Li J; Zhang C; Wen J; Zhu Y; Chang L; Wang H; Wang Q; Zhao W
Virol J; 2022 Dec; 19(1):223. PubMed ID: 36550578
[TBL] [Abstract][Full Text] [Related]
33. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
Balkhi MY
Mol Immunol; 2021 Jul; 135():268-275. PubMed ID: 33940513
[TBL] [Abstract][Full Text] [Related]
36. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
[TBL] [Abstract][Full Text] [Related]
37. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
38. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
[TBL] [Abstract][Full Text] [Related]
39. Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.
Younan P; Iampietro M; Nishida A; Ramanathan P; Santos RI; Dutta M; Lubaki NM; Koup RA; Katze MG; Bukreyev A
mBio; 2017 Sep; 8(5):. PubMed ID: 28951472
[TBL] [Abstract][Full Text] [Related]
40. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models.
Forbester JL; Clement M; Wellington D; Yeung A; Dimonte S; Marsden M; Chapman L; Coomber EL; Tolley C; Lees E; Hale C; Clare S; Udalova I; Dong T; Dougan G; Humphreys IR
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
